NVIDIA
NVDA
Disney
DIS
Cisco
CSCO
ASML Holding
ASML
Apple
AAPL
US Stock MarketDetailed Quotes
BCLI Brainstorm Cell Therapeutics
- 2.250
- +0.460+25.70%
Close Dec 18 16:00 ET
12.83MMarket Cap-0.65P/E (TTM)
2.400High1.780Low494.90KVolume1.840Open1.790Pre Close1.06MTurnover11.32%Turnover RatioLossP/E (Static)5.70MShares11.89052wk High-2.12P/B9.84MFloat Cap1.05052wk Low--Dividend TTM4.37MShs Float787.500Historical High--Div YieldTTM34.64%Amplitude1.050Historical Low2.150Avg Price1Lot Size
Trending US Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Brainstorm Cell Therapeutics Stock Forum
@MARKET-TEST-DUMMY 48 hours ago.
BrainStorm Strengthens Exosome Patent Portfolio: Receives Notice of Allowance for U.S. Patent Covering Its Platform Technology
Tuesday, 3rd December at 7:00 am
NEW YORK, Dec. 3, 2024 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, announced today that it has received Notice of Allowance from the U.S. Patent & Trademark Office (USPTO) for patent applica...
No comment yet